{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:30:03Z","timestamp":1792877403623,"version":"4.5.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270353"],"award-info":[{"award-number":["82270353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304935"],"award-info":[{"award-number":["82304935"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400404"],"award-info":[{"award-number":["82400404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174130"],"award-info":[{"award-number":["82174130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20250236"],"award-info":[{"award-number":["BX20250236"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cultivation of Lightening Stars","award":["23YF1448400"],"award-info":[{"award-number":["23YF1448400"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}]},{"name":"Three-year Action Plan for Shanghai TCM Development and Inheritance Program","award":["ZY(2021-2023)-0103"],"award-info":[{"award-number":["ZY(2021-2023)-0103"]}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2023 YZZ02"],"award-info":[{"award-number":["2023 YZZ02"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai \u2018Rising Stars of Medical Talents\u2019 Youth Development Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Hypertensive patients exhibit heightened susceptibility to pro-thrombotic state, elevating their cardiovascular event risk. G protein-coupled receptors (GPCRs) serve as central mediators of platelet function; however, the mechanisms through which GPCRs contribute to platelet hyperreactivity remain unclear. This study explores protease-activated receptor 4 (PAR4) on platelet hyperactivation in hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Platelet GPCR expression from 150 hypertensive patients, spontaneously hypertensive rats (SHRs), and L-NAME-induced hypertensive mice were analysed using RNA-seq and flow cytometry. In vivo and ex vivo thrombosis model, and in vitro platelet functional studies assessed PAR4 overexpression on platelet activation and confirmed by using PAR4-deficient mice. Megakaryocytes and transforming growth factor beta 1 (TGF-\u03b21)-deficient mice were employed to investigate transcriptional regulation of PAR4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PAR4 expression was elevated in platelets from hypertensive patients and positively correlated with integrin \u03b1\u2161b\u03b23 activation and P-selectin exposure, a finding validated in SHRs and hypertensive mice. PAR4 overexpression potentiated thrombin- and AYPGKF-induced platelet activation via Gq and G12\/13 signalling of PAR4 but not SFLLRN-induced platelet activation of PAR1, driving arterial thrombus formation. Mechanistic studies using TGF-\u03b21-deficient mice identified TGF-\u03b21 activated transcription factor Smad2, enabling its binding to the PAR4 promoter and PAR4 transcription upregulation. Angiotensin \u2161 initiated TGF-\u03b21\/Smad2 signalling, and valsartan, an angiotensin \u2161 receptor blocker (ARB), reduced PAR4 expression to attenuate thrombus formation in hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Angiotensin \u2161-driven TGF-\u03b21 upregulates platelet PAR4 transcription to enhance platelet activation in hypertension. Valsartan reverses platelet PAR4 overexpression to inhibit thrombus formation, revealing a new pleiotropic antithrombotic pharmacological mechanism of ARBs in hypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag632","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:54:13Z","timestamp":1785412453000},"source":"Crossref","is-referenced-by-count":1,"title":["Angiotensin II-driven TGF-\u03b21 increases platelet PAR4 expression enhancing thrombotic risk in hypertension"],"prefix":"10.1093","author":[{"given":"Mingzhu","family":"Wang","sequence":"first","affiliation":[{"name":"Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine , 110 Ganhe Road, Hongkou District, Shanghai 200437 ,","place":["China"]},{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Liu","sequence":"additional","affiliation":[{"name":"Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine , 110 Ganhe Road, Hongkou District, Shanghai 200437 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4346-6391","authenticated-orcid":false,"given":"Yufei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Huashan Hospital, Fudan University , 12 Urumqi Middle Road, Jing\u2019an District, Shanghai 200040 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Ma","sequence":"additional","affiliation":[{"name":"Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine , 110 Ganhe Road, Hongkou District, Shanghai 200437 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaorui","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Li","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong SAR ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-9626","authenticated-orcid":false,"given":"Zhichao","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Immunology, UConn Health School of Medicine , Farmington, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch , Galveston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchao","family":"Lu","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Huashan Hospital, Fudan University , 12 Urumqi Middle Road, Jing\u2019an District, Shanghai 200040 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Guo","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Fu","sequence":"additional","affiliation":[{"name":"Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine , 110 Ganhe Road, Hongkou District, Shanghai 200437 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-3913","authenticated-orcid":false,"given":"Liang","family":"Hu","sequence":"additional","affiliation":[{"name":"Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine , 110 Ganhe Road, Hongkou District, Shanghai 200437 ,","place":["China"]},{"name":"Cardiovascular Disease Research Center, The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Road, Pudong New District, Shanghai \u00a0 201203 ,","place":["China"]},{"name":"Department of Cardiology, Huashan Hospital, Fudan University , 12 Urumqi Middle Road, Jing\u2019an District, Shanghai 200040 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2026090309420227700_ehag632-B1","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jacc.2023.11.003","article-title":"A heart-healthy and stroke-free world: using data to inform global action","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026090309420227700_ehag632-B2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120\u2005mm Hg versus less than 140\u2005mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"2026090309420227700_ehag632-B3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/s0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"key":"2026090309420227700_ehag632-B4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/hypertensionaha.121.18192","article-title":"Hypertension pharmacological treatment in adults: a world health organization guideline executive summary","volume":"79","author":"Al-Makki","year":"2022","journal-title":"Hypertension"},{"key":"2026090309420227700_ehag632-B5","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090309420227700_ehag632-B6","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090309420227700_ehag632-B7","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1161\/strokeaha.122.038662","article-title":"Effect of hypertension on efficacy and safety of ticagrelor-aspirin versus clopidogrel-aspirin in minor stroke or transient ischemic attack","volume":"53","author":"Wang","year":"2022","journal-title":"Stroke"},{"key":"2026090309420227700_ehag632-B8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjcard.2019.07.044","article-title":"Association between hypertension, platelet reactivity, and the risk of adverse events after percutaneous coronary intervention (From the ADAPT-DES Study)","volume":"124","author":"Redfors","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026090309420227700_ehag632-B9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/circresaha.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"2026090309420227700_ehag632-B10","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"2026090309420227700_ehag632-B11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-beta in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026090309420227700_ehag632-B12","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1073\/pnas.97.7.3479","article-title":"Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and\/or target organ damage","volume":"97","author":"Suthanthiran","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090309420227700_ehag632-B13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cardiores.2007.02.008","article-title":"TGF-beta signaling in vascular fibrosis","volume":"74","author":"Ruiz-Ortega","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2026090309420227700_ehag632-B14","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/hypertensionaha.121.18684","article-title":"Platelet-derived TGF (transforming growth factor)-\u03b21 enhances the aerobic glycolysis of pulmonary arterial smooth muscle cells by PKM2 (pyruvate kinase muscle isoform 2) upregulation","volume":"79","author":"Zhu","year":"2022","journal-title":"Hypertension"},{"key":"2026090309420227700_ehag632-B15","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1161\/hypertensionaha.122.18657","article-title":"Ang II (Angiotensin II)-induced FGFR1 (fibroblast growth factor receptor 1) activation in tubular epithelial cells promotes hypertensive kidney fibrosis and injury","volume":"79","author":"Xu","year":"2022","journal-title":"Hypertension"},{"key":"2026090309420227700_ehag632-B16","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/atvbaha.117.309401","article-title":"TGF-\u03b2 (transforming growth factor-\u03b2) signaling protects the thoracic and abdominal aorta from Angiotensin II-induced pathology by distinct mechanisms","volume":"37","author":"Angelov","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B17","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1161\/circulationaha.111.082610","article-title":"Modulation of transforming growth factor-\u03b2 signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers","volume":"126","author":"Geirsson","year":"2012","journal-title":"Circulation"},{"key":"2026090309420227700_ehag632-B18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/cvr\/cvr067","article-title":"Angiotensin II increases periostin expression via Ras\/p38 MAPK\/CREB and ERK1\/2\/TGF-\u03b21 pathways in cardiac fibroblasts","volume":"91","author":"Li","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2026090309420227700_ehag632-B19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/circresaha.110.234369","article-title":"Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7","volume":"108","author":"He","year":"2011","journal-title":"Circ Res"},{"key":"2026090309420227700_ehag632-B20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1096\/fj.04-3032fje","article-title":"Transforming growth factor-beta1 enhances the antifibrinolytic and prothrombotic state of growing endothelial cells in a cell cycle-specific manner","volume":"20","author":"Stoldt","year":"2006","journal-title":"Faseb j"},{"key":"2026090309420227700_ehag632-B21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2005.07.026","article-title":"Identification of intracellular pathways through which TGF-beta1 upregulates PAI-1 expression in endothelial cells","volume":"186","author":"Woodward","year":"2006","journal-title":"Atherosclerosis"},{"key":"2026090309420227700_ehag632-B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.938397","article-title":"Platelet-derived TGF-beta1 is related to portal vein thrombosis in cirrhosis by promoting hypercoagulability and endothelial dysfunction","volume":"9","author":"Jiang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026090309420227700_ehag632-B23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/atvbaha.124.322395","article-title":"Transforming growth factors in venous thrombus formation and resolution","volume":"45","author":"Davis","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jacbts.2023.08.005","article-title":"Endothelial overexpression of TGF-beta-induced protein impairs venous thrombus resolution: possible role in CTEPH","volume":"9","author":"Bochenek","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"2026090309420227700_ehag632-B25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/strokeaha.123.042486","article-title":"Spatial proteomics analysis of soft and stiff regions in human acute arterial thrombus","volume":"54","author":"Mai","year":"2023","journal-title":"Stroke"},{"key":"2026090309420227700_ehag632-B26","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1182\/blood.2024025593","article-title":"N-homocysteinylation of \u03b2-arrestins biases GPCR signaling and promotes platelet activation","volume":"145","author":"Zhang","year":"2025","journal-title":"Blood"},{"key":"2026090309420227700_ehag632-B27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/circresaha.121.320530","article-title":"Unfolded protein response differentially modulates the platelet phenotype","volume":"131","author":"Jain","year":"2022","journal-title":"Circ Res"},{"key":"2026090309420227700_ehag632-B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci152373","article-title":"Platelet olfactory receptor activation limits platelet reactivity and growth of aortic aneurysms","volume":"132","author":"Morrell","year":"2022","journal-title":"J Clin Invest"},{"key":"2026090309420227700_ehag632-B29","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1161\/atvbaha.110.207522","article-title":"Signaling during platelet adhesion and activation","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02198-8","article-title":"Platelets and diseases: signal transduction and advances in targeted therapy","volume":"10","author":"Tian","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026090309420227700_ehag632-B31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/circulationaha.116.026995","article-title":"Platelets express activated P2Y(12) receptor in patients with diabetes mellitus","volume":"136","author":"Hu","year":"2017","journal-title":"Circulation"},{"key":"2026090309420227700_ehag632-B32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/ATVBAHA.120.316772","article-title":"Identification of a distinct platelet phenotype in the elderly: ADP hypersensitivity coexists with platelet PAR (protease-activated receptor)-1 and PAR-4-mediated thrombin resistance","volume":"42","author":"Gnanenthiran","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207722","article-title":"Increased pro-thrombotic platelet activity associated with thrombin\/PAR1-dependent pathway disorder in patients with secondary progressive multiple sclerosis","volume":"21","author":"Dziedzic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026090309420227700_ehag632-B34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ajh.22244","article-title":"Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury","volume":"87","author":"Muehlschlegel","year":"2012","journal-title":"Am J Hematol"},{"key":"2026090309420227700_ehag632-B35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/atvbaha.124.322068","article-title":"Attenuation of atherosclerosis with PAR4 deficiency: a potential role of hematopoietically expressed PAR4 in atherosclerosis-brief report","volume":"45","author":"Wadding-Lee","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"key":"2026090309420227700_ehag632-B37","doi-asserted-by":"publisher","DOI":"10.1172\/jci169608","article-title":"The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes","volume":"133","author":"Denorme","year":"2023","journal-title":"J Clin Invest"},{"key":"2026090309420227700_ehag632-B38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf5294","article-title":"Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding","volume":"9","author":"Wong","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026090309420227700_ehag632-B39","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/jth.15669","article-title":"Human and mouse PAR4 are functionally distinct receptors: studies in novel humanized mice","volume":"20","author":"Renna","year":"2022","journal-title":"J Thromb Haemost"},{"key":"2026090309420227700_ehag632-B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/glia.10012","article-title":"Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling","volume":"37","author":"Wang","year":"2002","journal-title":"Glia"},{"key":"2026090309420227700_ehag632-B41","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/jci94753","article-title":"Fibroblast-specific TGF-\u03b2-smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J Clin Invest"},{"key":"2026090309420227700_ehag632-B42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/cs20201213","article-title":"Negative regulators of TGF-\u03b21 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities","volume":"135","author":"Gifford","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"2026090309420227700_ehag632-B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01430-7","article-title":"Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions","volume":"8","author":"Ma","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026090309420227700_ehag632-B44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2026090309420227700_ehag632-B45","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/s0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"key":"2026090309420227700_ehag632-B46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1161\/strokeaha.124.048385","article-title":"Association of duration of recognized hypertension and stroke risk: the REGARDS study","volume":"56","author":"Howard","year":"2025","journal-title":"Stroke"},{"key":"2026090309420227700_ehag632-B47","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/eurheartj\/ehs368","article-title":"Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis","volume":"34","author":"Kumbhani","year":"2013","journal-title":"Eur Heart J"},{"key":"2026090309420227700_ehag632-B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1221438","article-title":"Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies","volume":"10","author":"Das","year":"2023","journal-title":"Front Nutr"},{"key":"2026090309420227700_ehag632-B49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/01.hyp.35.1.103","article-title":"Tyrosine phosphorylation of human platelet plasma membrane Ca(2+)-ATPase in hypertension","volume":"35","author":"Blankenship","year":"2000","journal-title":"Hypertension"},{"key":"2026090309420227700_ehag632-B50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay4860","article-title":"Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-beta","volume":"12","author":"Metelli","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026090309420227700_ehag632-B51","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1016\/S0021-9258(18)32345-7","article-title":"Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization","volume":"258","author":"Assoian","year":"1983","journal-title":"J Biol Chem"},{"key":"2026090309420227700_ehag632-B52","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1182\/bloodadvances.2017010868","article-title":"Platelet TGF-beta1 deficiency decreases liver fibrosis in a mouse model of liver injury","volume":"2","author":"Ghafoory","year":"2018","journal-title":"Blood Adv"},{"key":"2026090309420227700_ehag632-B53","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1182\/blood-2011-09-377648","article-title":"Platelet TGF-beta1 contributions to plasma TGF-beta1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload","volume":"119","author":"Meyer","year":"2012","journal-title":"Blood"},{"key":"2026090309420227700_ehag632-B54","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1161\/HYPERTENSIONAHA.120.15016","article-title":"Platelets promote Ang II (Angiotensin II)-induced atrial fibrillation by releasing TGF-beta1 (transforming growth factor-beta1) and interacting with fibroblasts","volume":"76","author":"Liu","year":"2020","journal-title":"Hypertension"},{"key":"2026090309420227700_ehag632-B55","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/bloodadvances.2018025817","article-title":"Inactivation of platelet-derived TGF-beta1 attenuates aortic stenosis progression in a robust murine model","volume":"3","author":"Varshney","year":"2019","journal-title":"Blood Adv"},{"key":"2026090309420227700_ehag632-B56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1182\/blood.2023022738","article-title":"Platelet-derived TGF-beta1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia","volume":"144","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"2026090309420227700_ehag632-B57","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1182\/blood.2020006389","article-title":"RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells","volume":"137","author":"Estevez","year":"2021","journal-title":"Blood"},{"key":"2026090309420227700_ehag632-B58","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood.V79.3.619.619","article-title":"Transforming growth factor beta inhibits megakaryocyte growth and endomitosis","volume":"79","author":"Kuter","year":"1992","journal-title":"Blood"},{"key":"2026090309420227700_ehag632-B59","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1161\/CIRCRESAHA.115.307016","article-title":"Platelet-mediated thrombosis: from bench to bedside","volume":"118","author":"Gurbel","year":"2016","journal-title":"Circ Res"},{"key":"2026090309420227700_ehag632-B60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41569-024-01062-6","article-title":"Reactive oxygen species in hypertension","volume":"22","author":"Camargo","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"2026090309420227700_ehag632-B61","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/CIRCRESAHA.124.324722","article-title":"Oxysterol sensing through GPR183 triggers endothelial senescence in hypertension","volume":"135","author":"Chu","year":"2024","journal-title":"Circ Res"},{"key":"2026090309420227700_ehag632-B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177524","article-title":"Toll-like receptor 9 contributes to perivascular adipose tissue dysfunction in spontaneously hypertensive rats","volume":"998","author":"Carvalho","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"2026090309420227700_ehag632-B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01577-3","article-title":"NAD(+) exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026090309420227700_ehag632-B64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/HYPERTENSIONAHA.122.20328","article-title":"Integrin CD11b contributes to hypertension and vascular dysfunction through mediating macrophage adhesion and migration","volume":"80","author":"Lin","year":"2023","journal-title":"Hypertension"},{"key":"2026090309420227700_ehag632-B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-023-09414-z","article-title":"Immune cells and hypertension","volume":"72","author":"Gan","year":"2024","journal-title":"Immunol Res"},{"key":"2026090309420227700_ehag632-B66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah4923","article-title":"Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension","volume":"9","author":"Kossmann","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026090309420227700_ehag632-B67","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/atvbaha.106.138693","article-title":"EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis","volume":"27","author":"Grothusen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B68","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/cvr\/cvy135","article-title":"Functional role of endothelial CXCL16\/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders","volume":"114","author":"Collado","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2026090309420227700_ehag632-B69","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/hr.2017.30","article-title":"Association between mean platelet volume and hypertension incidence","volume":"40","author":"Gang","year":"2017","journal-title":"Hypertens Res"},{"key":"2026090309420227700_ehag632-B70","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/atvbaha.115.307102","article-title":"Protease-activated receptor 4 variant p.Tyr157Cys reduces platelet functional responses and alters receptor trafficking","volume":"36","author":"Norman","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B71","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/atvbaha.118.311112","article-title":"Genetic variant in human PAR (protease-activated receptor) 4 enhances thrombus formation resulting in resistance to antiplatelet therapeutics","volume":"38","author":"Tourdot","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026090309420227700_ehag632-B72","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00432","article-title":"Analysis of the F2LR3 (PAR4) single nucleotide polymorphism (rs773902) in an indigenous Australian population","volume":"11","author":"Ningtyas","year":"2020","journal-title":"Front Genet"},{"key":"2026090309420227700_ehag632-B73","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jtha.2023.11.014","article-title":"Genetic and nongenetic drivers of platelet reactivity in healthy Tanzanian individuals","volume":"22","author":"Kullaya","year":"2024","journal-title":"J Thromb Haemost"},{"key":"2026090309420227700_ehag632-B74","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1182\/blood-2014-04-572479","article-title":"Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race","volume":"124","author":"Edelstein","year":"2014","journal-title":"Blood"},{"key":"2026090309420227700_ehag632-B75","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1111\/jth.14318","article-title":"The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y(12) inhibition","volume":"16","author":"Whitley","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2026090309420227700_ehag632-B76","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1182\/blood.2019004634","article-title":"PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153","volume":"136","author":"Han","year":"2020","journal-title":"Blood"},{"key":"2026090309420227700_ehag632-B77","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/CIRCRESAHA.121.318836","article-title":"Epigenetic regulation of F2RL3 associates with myocardial infarction and platelet function","volume":"130","author":"Corbin","year":"2022","journal-title":"Circ Res"},{"key":"2026090309420227700_ehag632-B78","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2016.02.056","article-title":"Validation of BARC bleeding criteria in patients with acute coronary syndromes: the TRACER trial","volume":"67","author":"Vranckx","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026090309420227700_ehag632-B79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41581-021-00414-6","article-title":"The evolving complexity of the collecting duct renin-angiotensin system in hypertension","volume":"17","author":"Prieto","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2026090309420227700_ehag632-B80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2026090309420227700_ehag632-B81","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026090309420227700_ehag632-B82","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/01.hyp.36.4.517","article-title":"Transforming growth factor beta in hypertensives with cardiorenal damage","volume":"36","author":"Laviades","year":"2000","journal-title":"Hypertension"},{"key":"2026090309420227700_ehag632-B83","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/sj.ki.5000034","article-title":"Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients","volume":"69","author":"G\u00f3mez-Garre","year":"2006","journal-title":"Kidney Int"},{"key":"2026090309420227700_ehag632-B84","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ (Clinical research ed.)"},{"key":"2026090309420227700_ehag632-B85","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/s0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"2026090309420227700_ehag632-B86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jash.2015.11.005","article-title":"Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension","volume":"10","author":"Akioyamen","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"2026090309420227700_ehag632-B87","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"2026090309420227700_ehag632-B88","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cvr\/cvp091","article-title":"Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src\/PI3K\/Akt signalling","volume":"82","author":"Su","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2026090309420227700_ehag632-B89","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jamacardio.2023.0065","article-title":"Effect of sacubitril\/valsartan vs valsartan on left atrial volume in patients with pre-heart failure with preserved ejection fraction: the PARABLE randomized clinical trial","volume":"8","author":"Ledwidge","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026090309420227700_ehag632-B90","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1074\/jbc.275.10.6819","article-title":"Cathepsin G activates protease-activated receptor-4 in human platelets","volume":"275","author":"Sambrano","year":"2000","journal-title":"J Biol Chem"},{"key":"2026090309420227700_ehag632-B91","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09537100902803635","article-title":"Regulation of plasmin-induced protease-activated receptor 4 activation in platelets","volume":"20","author":"Mao","year":"2009","journal-title":"Platelets"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag632\/70942802\/ehag632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag632\/70942802\/ehag632.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:42:24Z","timestamp":1788442944000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag632\/8781141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":91,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag632","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"ehag632"}}